Recombinant Human SPLUNC2 Protein(HEK293)，His

SPLUNC2 (Short palate, lung, and nasal epithelium clone 2) is a protein primarily expressed in the respiratory and nasal epithelia, where it plays a crucial role in innate immunity and mucosal defense. It is part of the broader SPLUNC family, which is known for its involvement in maintaining airway homeostasis and regulating inflammatory responses. Recent studies have highlighted SPLUNC2's various functions, including antibacterial activity, modulation of mucin secretion, and protective roles against respiratory pathogens, suggesting its potential as a biomarker for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Given its diverse functions and involvement in epithelial barrier integrity, researchers are increasingly focused on understanding the molecular mechanisms underlying SPLUNC2's activity. This includes examining the protein's structure-function relationship, its interactions with other biomolecules, and its regulatory pathways. The recombinant expression of SPLUNC2 can facilitate the investigation of its biological properties and therapeutic potential. By producing large quantities of the protein, researchers aim to conduct functional assays and elucidate its role in inflammation and host defense mechanisms. Additionally, SPLUNC2's potential as a therapeutic target or biomarker has drawn attention in the context of developing novel treatments for respiratory conditions, emphasizing the importance of ongoing research into this multifaceted protein. Overall, the study of SPLUNC2 not only contributes to our understanding of respiratory biology but also paves the way for innovative approaches to combat respiratory diseases.